These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38741835)

  • 61. Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice.
    Ho AM; Qiu Y; Jia YF; Aguiar FS; Hinton DJ; Karpyak VM; Weinshilboum RM; Choi DS
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1531-9. PubMed ID: 27184383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association Between Alcohol Craving and Health-Related Quality of Life Among Veterans With Co-occurring Conditions.
    Herrold AA; Pape TL; Li X; Jordan N
    Mil Med; 2017 Jul; 182(7):e1712-e1717. PubMed ID: 28810962
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD Study.
    Heng S; Jamshidi N; Baillie A; Louie E; Dore G; Phung N; Haber PS; Morley KC
    Front Psychiatry; 2018; 9():576. PubMed ID: 30524317
    [No Abstract]   [Full Text] [Related]  

  • 64. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
    Morgane GL; Delphine LG; Guillaume K; Yves LJ
    Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.
    de Sousa A; de Sousa A
    Alcohol Alcohol; 2005; 40(6):545-8. PubMed ID: 16043433
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.
    Witte J; Bentley K; Evins AE; Clain AJ; Baer L; Pedrelli P; Fava M; Mischoulon D
    J Clin Psychopharmacol; 2012 Dec; 32(6):787-96. PubMed ID: 23131884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlates of Baclofen Effectiveness in Alcohol Dependence.
    Shukla L; Shukla T; Bokka S; Kandasamy A; Benegal V; Murthy P; Chand P
    Indian J Psychol Med; 2015; 37(3):370-3. PubMed ID: 26664095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
    Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
    Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determination of the Relationship Between Craving and 4-repeat Allele of
    Kaya H; Akkişi Kumsar N; Civan Kahve A; Bolat Kaya Ö; Dilbaz N
    Alpha Psychiatry; 2021 Mar; 22(2):73-78. PubMed ID: 36425930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.
    Leggio L; Ferrulli A; Cardone S; Miceli A; Kenna GA; Gasbarrini G; Swift RM; Addolorato G
    Alcohol; 2008 Aug; 42(5):375-81. PubMed ID: 18486430
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.
    Colombo G; Addolorato G; Agabio R; Carai MA; Pibiri F; Serra S; Vacca G; Gessa GL
    Neurotox Res; 2004; 6(5):403-14. PubMed ID: 15545024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder.
    Mellick WH; Tolliver BK; Brenner HM; Anton RF; Prisciandaro JJ
    JAMA Psychiatry; 2023 Nov; 80(11):1150-1159. PubMed ID: 37556131
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple Sessions of Transcranial Direct Current Stimulation (tDCS) Reduced Craving and Relapses for Alcohol Use: A Randomized Placebo-Controlled Trial in Alcohol Use Disorder.
    Klauss J; Anders QS; Felippe LV; Nitsche MA; Nakamura-Palacios EM
    Front Pharmacol; 2018; 9():716. PubMed ID: 30018558
    [No Abstract]   [Full Text] [Related]  

  • 74. Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence.
    Morley KC; Louie E; Hurzeler T; Baillie A; Dore G; Phung N; Haber PS
    Front Glob Womens Health; 2022; 3():807269. PubMed ID: 35425938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
    Burnette EM; Baskerville WA; Grodin EN; Ray LA
    Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alcohol use and craving among Veterans with mental health disorders and mild traumatic brain injury.
    Herrold AA; Jordan N; High WM; Babcock-Parziale J; Chambers RA; Smith B; Evans CT; Li X; Mallinson T; Jenkins S; Pape TL
    J Rehabil Res Dev; 2014; 51(9):1397-410. PubMed ID: 26736027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
    Antonelli M; Sestito L; Tarli C; Addolorato G
    Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Factors influencing adherence to anti-craving medications and drinking outcomes in patients with alcohol dependence: A hospital-based study.
    Lohit K; Kulkarni C; Galgali RB
    J Pharmacol Pharmacother; 2016; 7(2):72-9. PubMed ID: 27440951
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imaging Nociceptin Opioid Peptide Receptors in Alcohol Use Disorder With [
    Tollefson S; Stoughton C; Himes ML; McKinney KE; Mason S; Ciccocioppo R; Narendran R
    Biol Psychiatry; 2023 Sep; 94(5):416-423. PubMed ID: 36906499
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.